subject: GTOPDB:13710

subject_name: pelacarsen

object_name: Inflammation


subject: GTOPDB:13710

object_name: lipoproteinemia

tested_intervention: unsure


subject: GTOPDB:13710

object_name: acute coronary syndrome


subject: DRUGBANK:DB16284

subject_name: Pelacarsen


subject: DRUGBANK:DB16284


subject: DRUGBANK:DB16284


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Breast cancer stage II


subject: CHEBI:49603

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:49603

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:49603

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C2095775

subject_name: ampicillins

object_name: premature birth (history)


subject: CHEBI:28971

subject_name: Ampicillin


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:9964861

subject_name: PRAMIPEXOLE HCl

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:9964861

object_name: bipolar depression


subject: CHEBI:51147

subject_name: pramipexole hydrochloride


subject: CHEBI:51147


subject: CHEBI:182913

subject_name: Dexpramipexole


subject: CHEBI:8356

subject_name: Pramipexole

tested_intervention: yes


subject: PR:000017503

subject_name: solute carrier family 53 member 1


subject: PR:000017503


subject: PR:000006336

subject_name: L-xylulose reductase


subject: PR:000006336


subject: CHEBI:84363

object_name: orthostatic hypotension


subject: CHEBI:84363

object_name: pure autonomic failure


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:2376


subject: CHEBI:50634


subject: CHEBI:50634


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:127342

subject_name: Atomoxetine


subject: CHEBI:127342


subject: CHEBI:3395

subject_name: carbidopa


subject: CHEBI:3395


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:94430


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:15765

subject_name: Levodopa


subject: CHEBI:15765


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:8776


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:190463


subject: CHEBI:190463


subject: CHEBI:64318

subject_name: Ergotamine


subject: CHEBI:64318


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:27732


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:49662

subject_name: Indomethacin


subject: CHEBI:49662


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:6887


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:51209

subject_name: Pseudoephedrine


subject: CHEBI:8665

subject_name: Pyridostigmine


subject: PUBCHEM.COMPOUND:9952812

subject_name: RIVASTIGMINE TARTRATE


subject: PUBCHEM.COMPOUND:9952812


subject: CHEBI:8874

subject_name: Rivastigmine


subject: CHEBI:8874


subject: PUBCHEM.COMPOUND:73417116

subject_name: TRANYLCYPROMINE


subject: PUBCHEM.COMPOUND:73417116


subject: CHEBI:182949

subject_name: Tranylcypromine


subject: CHEBI:182949


subject: CHEBI:10093

subject_name: Yohimbine


subject: CHEBI:90841

subject_name: Cangrelor

object_name: acute myocardial infarction


subject: CHEBI:90841

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C0701413

subject_name: Sol brand of Polymethyl Methacrylate

object_name: colorectal cancer


subject: UMLS:C0701413

object_name: colorectal carcinoma


subject: UMLS:C0701413

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:45783

subject_name: Imatinib

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:45783

object_name: lymphoblastic leukemia, acute, with lymphomatous features


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UMLS:C1328139


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: Nodal T-follicular helper cell lymphoma, follicular type


subject: PUBCHEM.COMPOUND:58008990

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: PUBCHEM.COMPOUND:58008990

object_name: angioimmunoblastic T-cell lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: monomorphic epitheliotropic intestinal T-cell lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C3897088

subject_name: Oral Azacitidine


subject: UMLS:C3897088

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C3897088


subject: UMLS:C3897088


subject: UMLS:C3897088

object_name: enteropathy-associated T-cell lymphoma


subject: UMLS:C3897088


subject: UMLS:C3897088


subject: PUBCHEM.COMPOUND:23668620

subject_name: amphotericin B, deoxycholate drug combination

object_name: Aspergilloma


subject: PUBCHEM.COMPOUND:23668620

object_name: Chronic pulmonary aspergillosis


subject: PUBCHEM.COMPOUND:23668620

object_name: congenital primary aphakia


subject: UNII:44WG8E9MTU

subject_name: AMPHOTERICIN B DEOXYCHOLATE


subject: UNII:44WG8E9MTU


subject: UNII:44WG8E9MTU


subject: CHEBI:404903

subject_name: Ertapenem

object_name: Acute appendicitis without peritonitis


subject: CHEBI:135720

subject_name: Deflazacort

object_name: allergic bronchopulmonary aspergillosis


subject: CHEBI:94534

subject_name: olanzapine

object_name: Neuroleptic-Induced Tardive Dyskinesia


subject: UNII:44707RLQ6U

object_name: schizophrenia


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: inflammatory bowel disease 1


subject: UNII:4EQZ6YO2HI

object_name: Crohn disease


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: female reproductive system disorder


subject: CHEBI:31527

object_name: male reproductive system disorder


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: UMLS:C5203179

subject_name: Adalimumab Liquid Injection

object_name: meningeal tuberculosis


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: CHEBI:44185

subject_name: Methotrexate

object_name: Childhood Hematopoietic and Lymphoid Cell Neoplasm


subject: CHEBI:87631

subject_name: statin

object_name: cerebrovascular disorder


subject: CHEBI:87631

object_name: Stroke (heart beat)


subject: CHEBI:87631

object_name: Stroke, CTCAE


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Solid Neoplasm


subject: UMLS:C1328149

object_name: breast neoplasm


subject: UMLS:C4329302

subject_name: Androgen Receptor Antagonist TRC253

object_name: prostate adenocarcinoma


subject: CHEBI:6427

subject_name: Leuprolide

object_name: Depressed mood


subject: CHEBI:6427

object_name: Cancer patients and suicide and depression


subject: CHEBI:6427

object_name: Depressed - symptom


subject: CHEBI:6427

object_name: Depression, CTCAE


subject: CHEBI:9654

subject_name: Trazodone

object_name: fibromyalgia


subject: PUBCHEM.COMPOUND:44210114

subject_name: Lurasidone


subject: PUBCHEM.COMPOUND:44210114


subject: PUBCHEM.COMPOUND:44210114


subject: PUBCHEM.COMPOUND:44210114


subject: GTOPDB:6803

subject_name: dalteparin

object_name: traumatic encephalopathy


subject: GTOPDB:6803

object_name: traumatic brain injury


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: post operative nausea and vomiting


subject: MESH:C000656652

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:O13QTC8612

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:135582802

subject_name: CEFTOBIPROLE MEDOCARIL

object_name: Bacteremia caused by Staphylococcus aureus


subject: UNII:N99027V28J


subject: PUBCHEM.COMPOUND:135456161


subject: CHEBI:140407

subject_name: Ceftobiprole


subject: UMLS:C4721871

subject_name: COX-2 Inhibitor TG01

object_name: smoldering plasma cell myeloma


subject: UMLS:C4721871

object_name: plasma cell myeloma


subject: UMLS:C5849104

subject_name: RAS Peptide Cancer Vaccine TG01


subject: UMLS:C5849104


subject: CHEMBL.COMPOUND:CHEMBL2108741

subject_name: SIMETICONE

object_name: Constipation


subject: CHEMBL.COMPOUND:CHEMBL2108741

object_name: Constipation, CTCAE


subject: CHEBI:31498

subject_name: Simethicone


subject: CHEBI:31498


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:2955

subject_name: Azithromycin

object_name: HIV disease progression


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Rotator Cuff Injuries


subject: CHEBI:6129

object_name: Rotator Cuff Injury, CTCAE


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: rotator cuff syndrome


subject: PUBCHEM.COMPOUND:633097

object_name: Rotator cuff tear


subject: PUBCHEM.COMPOUND:633097

object_name: Rotator Cuff Tendinitis


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Chronic abdominal pain


subject: CHEBI:231350

subject_name: Pacritinib

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:231350

object_name: non-small cell lung carcinoma


subject: CHEBI:231350

object_name: lung cancer


subject: PUBCHEM.COMPOUND:2269

object_name: Critical Illness


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955


subject: UMLS:C5242207

subject_name: Sambucol

object_name: influenza


subject: UMLS:C3536784

subject_name: cytomegalovirus immune globulin, intravenous

object_name: end stage renal failure


subject: UMLS:C3536784

object_name: Chronic uremia


subject: UMLS:C0057002

subject_name: cytomegalovirus immune globulin


subject: UMLS:C0057002


subject: UMLS:C0719605

subject_name: Cytogam


subject: UNII:6897GXD6OE

object_name: glucose metabolism disease


subject: UNII:6897GXD6OE

object_name: Glucose metabolism disorders (incl diabetes mellitus)


subject: UNII:6897GXD6OE

object_name: iron poisoning


subject: UNII:6897GXD6OE

object_name: iron toxicity


subject: UNII:6897GXD6OE

object_name: Safety Issues


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Maternal Hypotension


subject: UMLS:C0392938

subject_name: zoledronate

object_name: postmenopausal osteoporosis


subject: PUBCHEM.COMPOUND:23431961

subject_name: Sodium citrate

object_name: ANTICOAGULATION (finding)


subject: CHEBI:30769

subject_name: Citric acid


subject: UMLS:C4733592

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4733592

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:P7UV3L2H80

subject_name: levilimab


subject: UMLS:C5418030


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: Menkes disease


subject: UNII:3ZY6J6Z6EE

object_name: occipital horn syndrome


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: hypogonadism


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: failure; transplant, kidney


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:22586

subject_name: antioxidant

object_name: amyotrophic lateral sclerosis


subject: UMLS:C0003402

subject_name: Antioxidants


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Catheter site pain


subject: CHEBI:34618

subject_name: ceftibuten dihydrate

object_name: dilated cardiomyopathy 1B


subject: CHEBI:3510

subject_name: Ceftibuten


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:C5F376EKS2

subject_name: LEDABORBACTAM ETZADROXIL


subject: UMLS:C5669584

subject_name: Ledaborbactam Etzadroxil


subject: PUBCHEM.COMPOUND:101742774

object_name: chronic pancreatitis


subject: UMLS:C2003775


subject: UMLS:C2003774

subject_name: benzoyl-tyrosyl-alanine


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:75998

subject_name: Trametinib


subject: UMLS:C1630394

subject_name: ethinyl estradiol / gestodene

object_name: adenomyosis


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: upper GI cancer


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Muscle Atrophy


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL


subject: CHEMBL.COMPOUND:CHEMBL2107910

object_name: chronic obstructive pulmonary disease


subject: CHEBI:145499

subject_name: Donepezil

object_name: Sleep Deprivation


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN

object_name: Acute Ischemic Stroke


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: CHEBI:48720

subject_name: argatroban


subject: CHEBI:6801

subject_name: Metformin

object_name: beriberi


subject: CHEBI:6801

object_name: Thiamine deficiency


subject: CHEBI:6801

object_name: Decreased circulating vitamin B1 concentration


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:114785

subject_name: Erlotinib

object_name: psoriasis


subject: PUBCHEM.COMPOUND:25087507

subject_name: Human lactoferrin peptide 1-11

object_name: Bacterial Infections and Mycoses


subject: UMLS:C5417912

subject_name: MEK 1/2 Inhibitor FCN-159

object_name: Langerhans cell histiocytosis


subject: UMLS:C5417912

object_name: Langerhans cell histiocytosis specific to childhood


subject: UMLS:C5417912

object_name: Langerhans cell histiocytosis specific to adulthood


subject: UMLS:C5417912

object_name: lissencephaly with cerebellar hypoplasia


subject: UMLS:C2350951

object_name: Alzheimer disease


subject: CHEBI:6931

subject_name: Midazolam

object_name: Maternity blues


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: otitis media


subject: CHEBI:51254

object_name: Otitis Media, CTCAE


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:487869

subject_name: clavulanate


subject: CHEBI:487869

object_name: infectious otitis media


subject: CHEBI:487869


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:3396

subject_name: Carbidopa-levodopa

object_name: age-related macular degeneration


subject: UMLS:C0353697

subject_name: carbidopa / levodopa


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: Inflammatory abnormality of the eye


subject: PUBCHEM.COMPOUND:633097

object_name: Postoperative Complications


subject: PUBCHEM.COMPOUND:633097

object_name: ocular hypertension


subject: PUBCHEM.COMPOUND:633097

object_name: Ocular hypertension


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: carcinoma of urethra


subject: CHEBI:45863

object_name: urethra cancer


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: knee pain chronic


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:4315

subject_name: Danazol

object_name: Short telomere length


subject: UMLS:C3177398

subject_name: DLBS 1033

object_name: ST-elevation myocardial infarction


subject: UMLS:C3177398

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:65209

subject_name: Lucitanib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:65209

object_name: female reproductive organ cancer


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Ileal Pouches


subject: PUBCHEM.COMPOUND:435949

object_name: pouchitis


subject: PUBCHEM.COMPOUND:435949

object_name: Ileoanal Pouches


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:33330

subject_name: scandium atom


subject: CHEBI:33330


subject: CHEBI:33330


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: PR:000050188


subject: CHEBI:167309

subject_name: Methadone

object_name: Postoperative Pain, Acute


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Cardiovascular event


subject: CHEBI:3723

subject_name: Citalopram


subject: UNII:HM5641GA6F

subject_name: Oprelvekin

object_name: ulcerative colitis


subject: UMLS:C0537668

subject_name: Neumega


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: carcinoma of esophagus


subject: CHEBI:50275

object_name: esophageal cancer


subject: CHEBI:50275

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:50275

object_name: neoplasm of esophagus


subject: CHEBI:50275

object_name: precancerous condition


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Metastatic Breast Carcinoma in the Brain


subject: CHEBI:85993

object_name: HER2 positive


subject: CHEBI:85993

object_name: Progesterone Receptor Negative


subject: CHEBI:85993

object_name: Estrogen Receptor Negative


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: schizophrenia


subject: UNII:08WG8S0L8D

object_name: Childhood Solid Neoplasm


subject: UNII:08WG8S0L8D

object_name: Adult Solid Neoplasm


subject: UNII:08WG8S0L8D

object_name: Solid Neoplasm


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Inguinal hernia


subject: CHEBI:39501

subject_name: trientine

object_name: melanoma


subject: CHEBI:9434

subject_name: Telmisartan

object_name: adult acute respiratory distress syndrome


subject: CHEBI:9434

object_name: respiratory failure


subject: CHEBI:9434

object_name: bronchopulmonary dysplasia


subject: CHEBI:9434

object_name: Respiratory insufficiency


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: Bronchiolitis, Viral


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: follicular lymphoma


subject: UNII:6QVL057INT

object_name: mantle cell lymphoma


subject: UNII:6QVL057INT

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:6QVL057INT

object_name: non-Hodgkin lymphoma


subject: UNII:6QVL057INT

object_name: Recurrent tumor


subject: UNII:6QVL057INT

object_name: diffuse large B-cell lymphoma


subject: UNII:6QVL057INT

object_name: Recurrent Uveal Melanoma


subject: UNII:6QVL057INT

object_name: in situ carcinoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C5907941

subject_name: Dual-activating Polyvalent STING Agonist ONM-501

object_name: Childhood Solid Neoplasm


subject: UMLS:C5907941

object_name: Adult Solid Neoplasm


subject: UMLS:C5907941

object_name: Solid Neoplasm


subject: UMLS:C5907941


subject: UMLS:C5907941


subject: UMLS:C5907941


subject: UMLS:C5907941


subject: UMLS:C5907941


subject: UMLS:C5907941


subject: UMLS:C5907941

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5907941

object_name: triple-negative breast carcinoma


subject: UMLS:C5907941

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5907941


subject: UMLS:C5907941

object_name: skin neoplasm


subject: UMLS:C5907941

object_name: skin cancer


subject: UMLS:C5907941

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5907941

object_name: Embolism, Tumor


subject: UMLS:C5907941

object_name: Neoplasm Metastasis


subject: UMLS:C5907941


subject: UMLS:C5907941

object_name: bladder tumor


subject: UMLS:C5907941

object_name: urinary bladder carcinoma


subject: UMLS:C5907941

object_name: urinary bladder cancer


subject: UMLS:C5907941

object_name: childhood bladder carcinoma


subject: UMLS:C5907941

object_name: cervical cancer


subject: UMLS:C5907941

object_name: cervical carcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: No Evidence of Disease


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: MESH:C557213


subject: RXCUI:34246

subject_name: Polytrim eyedrops

object_name: conjunctivitis


subject: RXCUI:34246

object_name: Conjunctivitis, CTCAE


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: epilepsy


subject: CHEBI:6078

subject_name: Ivermectin


subject: UMLS:C0306371

subject_name: Humulin R

object_name: aortic aneurysm


subject: UMLS:C0306371

object_name: Aortic aneurysm without mention of rupture NOS


subject: UMLS:C0306371

object_name: myocardial ischemia


subject: UMLS:C0306371

object_name: Family history of ischemic heart disease


subject: CHEBI:74120

subject_name: Gly-Met

object_name: neurotoxicity


subject: CHEBI:19229


subject: UniProtKB:P16733

subject_name: GM_HCMVA Envelope glycoprotein M (sprot)


subject: CHEBI:139072

object_name: non-small cell lung carcinoma


subject: CHEBI:8614

subject_name: Psilocybin


subject: UNII:O880NM097T

subject_name: Avacopan

object_name: Acne inversa


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: pancreatic neoplasm


subject: CHEBI:46058

object_name: exocrine pancreatic carcinoma


subject: CHEBI:46058

object_name: malignant pancreatic neoplasm


subject: UMLS:C4287772

object_name: Cushing syndrome


subject: UMLS:C4287772

object_name: hyperaldosteronism


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: tropical spastic paraparesis


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: hypospadias


subject: CHEBI:3770

object_name: Penile hypospadias


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C3896834

subject_name: Dna plasmid encoding interleukin-12 ino-9012

object_name: Klatskin Tumor


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: cancer pain


subject: PUBCHEM.COMPOUND:9848990

object_name: cancer


subject: PUBCHEM.COMPOUND:9848990

object_name: neoplasm


subject: UMLS:C3658638

object_name: Childhood Breast Carcinoma


subject: UMLS:C3658638

object_name: breast cancer


subject: UMLS:C4733292

object_name: actinic keratosis


subject: UMLS:C5854411

subject_name: Chk1 Inhibitor PEP07

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5854411

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:71013

subject_name: Perampanel

object_name: alcohol abuse


subject: CHEBI:71013

object_name: alcohol dependence


subject: UMLS:C4079170

object_name: opiate dependence


subject: UMLS:C4079170

object_name: Substance Use Disorders


subject: UMLS:C4079170

object_name: Dopamine dysregulation syndrome


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Malignant tumor of digestive organ


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C5667024


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:32188

subject_name: Tegafur


subject: CHEBI:31652

subject_name: Gimeracil


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:195181

subject_name: Alanylalanine

object_name: Prostatic Cancer, Castration-Resistant


subject: CHEBI:15843

subject_name: Arachidonate


subject: UMLS:C0002520

subject_name: Amino Acids


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Parkinson disease


subject: MESH:D000077331

subject_name: Ringer's Solution

object_name: no feeling or sensation of skin


subject: MESH:D000077331

object_name: Sensory Loss


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UNII:Q6C9WHR03O

object_name: B-cell acute lymphoblastic leukemia


subject: UMLS:C2974969

subject_name: Nerofe

object_name: Ovarian cancer stage IV


subject: UMLS:C2974969

object_name: triple-negative breast carcinoma


subject: UMLS:C2974969

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: lung cancer


subject: CHEBI:229221

object_name: lung neoplasm


subject: CHEBI:229221

object_name: lung carcinoma


subject: UMLS:C2364569

subject_name: rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain

object_name: diarrhea


subject: UMLS:C2364569

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C2364569

object_name: Diarrhea, CTCAE


subject: UMLS:C4331032

subject_name: Cx-072 probody

object_name: Childhood Breast Carcinoma


subject: UMLS:C4331032

object_name: breast carcinoma


subject: UMLS:C4331032

object_name: breast cancer


subject: UMLS:C4331032


subject: UMLS:C4331032

object_name: breast neoplasm


subject: UMLS:C4331032

object_name: neoplasm


subject: UMLS:C4525309


subject: UMLS:C4525309


subject: UMLS:C4525309


subject: UMLS:C4525309


subject: UMLS:C4525309


subject: UMLS:C4525309


subject: PUBCHEM.COMPOUND:138115136

object_name: diabetic macular edema


subject: UMLS:C3661273


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Depressed mood


subject: UNII:ZL1R02VT79

object_name: Cancer patients and suicide and depression


subject: UNII:ZL1R02VT79

object_name: Depressed - symptom


subject: UNII:ZL1R02VT79

object_name: Depression, CTCAE


subject: UMLS:C5556553

subject_name: Anti-B7-H4 Monoclonal Antibody NC762

object_name: non-small cell lung carcinoma


subject: UMLS:C5556553

object_name: ovarian cancer


subject: UMLS:C5556553

object_name: ovarian neoplasm


subject: UMLS:C5556553

object_name: ovarian carcinoma


subject: UMLS:C5556553


subject: UMLS:C5556553


subject: UMLS:C5556553


subject: GTOPDB:12989

object_name: Clear-cell metastatic renal cell carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337


subject: CHEBI:3374

subject_name: Capsaicin

object_name: inherited lipid metabolism disorder


subject: CHEBI:3374

object_name: Dyslipidemia


subject: CHEBI:3374

object_name: Overweight or obesity


subject: CHEBI:174615

object_name: refractory hairy cell leukemia


subject: CHEBI:174615

object_name: chronic neutrophilic leukemia


subject: CHEBI:174615

object_name: chronic eosinophilic leukemia


subject: CHEBI:174615

object_name: mastocytosis


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: PUBCHEM.COMPOUND:3367

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: PUBCHEM.COMPOUND:3367

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:3367

object_name: recurrent cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: adult acute myeloid leukemia with del(5q)


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:3367

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:3367

object_name: T-cell large granular lymphocyte leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: Secondary Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:3367

object_name: refractory hairy cell leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: chronic neutrophilic leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: chronic eosinophilic leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: mastocytosis


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Disorder related to renal transplantation


subject: UMLS:C0003448

subject_name: Antitubercular Agents

object_name: Tuberculous uveitis


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)

object_name: Unexplained infertility


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: CHEBI:36791

subject_name: Escitalopram

object_name: irritable bowel syndrome


subject: CHEBI:3723

subject_name: Citalopram


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: asthma


subject: UNII:7BA3X03948

subject_name: BERUBICIN HYDROCHLORIDE

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C2713012

subject_name: Berubicin Hydrochloride


subject: DRUGBANK:DB05920

subject_name: RTA 744


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Radiation Sickness


subject: UMLS:C1527137

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C1527137

object_name: Embolism, Tumor


subject: UMLS:C1527137

object_name: Neoplasm Metastasis


subject: UMLS:C1527137

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:47657

subject_name: Roflumilast

object_name: Non-cystic fibrosis bronchiectasis


subject: UMLS:C5555587

subject_name: Anti-c-Met/MMAE ADC RC108

object_name: non-small cell lung carcinoma


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab

object_name: Metastatic osteosarcoma


subject: UNII:7SQY4ZUD30

object_name: Secondary malignant neoplasm of lung


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:231678

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:231678

object_name: acute myeloid leukemia


subject: CHEBI:231678

object_name: acute lymphoblastic leukemia


subject: RXCUI:1656336

subject_name: sacubitril / valsartan Oral Product

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: hip fracture


subject: PUBCHEM.COMPOUND:3467

object_name: Prosthetic infection


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:3745


subject: CHEBI:15365

subject_name: Aspirin

object_name: Fractured ankle


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: poisoning


subject: CHEBI:3764

subject_name: Clotrimazole

object_name: Mycoses


subject: CHEBI:3764

object_name: tinea cruris


subject: CHEBI:3764

object_name: tinea corporis


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C1258613

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C1258613

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C1258613

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UMLS:C1258613

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UMLS:C1258613

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: juvenile dermatomyositis


subject: UNII:73B0K5S26A

object_name: myositis


subject: UNII:73B0K5S26A

object_name: Myositis, CTCAE 5.0


subject: CHEBI:15365

object_name: Moderate albuminuria


subject: CHEBI:28864

subject_name: Tobramycin

object_name: vernal keratoconjunctivitis


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UNII:1C6V77QF41

object_name: Anemia of inadequate production


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: complications; renal, allograft


subject: UMLS:C5964774

subject_name: Oncolytic Adenovirus Ad5-DNX-2401

object_name: Recurrent Childhood Gliosarcoma


subject: UMLS:C5964774

object_name: Recurrent Gliosarcoma


subject: UMLS:C5964774

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C5964774

object_name: Recurrent Glioblastoma


subject: UMLS:C5964774

object_name: Recurrent Malignant Glioma


subject: UMLS:C5964774

object_name: Recurrent Anaplastic Astrocytoma


subject: UMLS:C5964774

object_name: Recurrent Childhood Anaplastic Astrocytoma


subject: UMLS:C2930786

object_name: ovarian cancer


subject: UMLS:C2930786

object_name: ovarian neoplasm


subject: UMLS:C1831775


subject: UMLS:C1831775


subject: CHEBI:16335

subject_name: Adenosine

object_name: aneurysm


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Pediatric Disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: Metastatic non-small cell lung cancer


subject: UNII:R8DG7T2D3A

object_name: Metastatic Lung Carcinoma in the Brain


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UMLS:C3257534

subject_name: wheat bran extract

object_name: Overweight


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Intensive care unit syndrome


subject: CHEBI:63598

subject_name: Levofloxacin


subject: GTOPDB:12990

subject_name: sintilimab

object_name: endometrioid adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:DPT0O3T46P


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: mismatch repair cancer syndrome 1


subject: CHEBI:6715

object_name: Turcot syndrome


subject: CHEBI:6715

object_name: Mismatch Repair Deficiency


subject: CHEBI:138016

subject_name: MPA

object_name: endometrial cancer


subject: CHEBI:138016

object_name: uterine corpus cancer


subject: CHEBI:138016

object_name: endometrial carcinoma


subject: CHEBI:138016


subject: CHEBI:138016


subject: CHEBI:138016


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: CHEBI:17026


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: CHEBI:73610

subject_name: Met-Ala


subject: CHEBI:73610


subject: CHEBI:73610


subject: CHEBI:73610


subject: CHEBI:73610


subject: CHEBI:73610


subject: CHEBI:73610


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:6810

subject_name: Metandienone


subject: CHEBI:6810


subject: CHEBI:6810


subject: CHEBI:6810


subject: CHEBI:6810


subject: CHEBI:6810


subject: CHEBI:6810


subject: CHEBI:474859

subject_name: maleic anhydride


subject: CHEBI:474859


subject: CHEBI:474859


subject: CHEBI:474859


subject: CHEBI:474859


subject: CHEBI:474859


subject: CHEBI:474859


subject: PR:000033943

subject_name: class II histocompatibility antigen, M alpha chain


subject: PR:000033943


subject: PR:000033943


subject: PR:000033943


subject: PR:000033943


subject: PR:000033943


subject: PR:000033943


subject: UniProtKB:P28078

subject_name: DMA_MOUSE Class II histocompatibility antigen, M alpha chain (sprot)


subject: UniProtKB:P28078


subject: UniProtKB:P28078


subject: UniProtKB:P28078


subject: UniProtKB:P28078


subject: UniProtKB:P28078


subject: UniProtKB:P28078


subject: CHEBI:137064

subject_name: Galunisertib

object_name: prostate carcinoma


subject: CHEBI:137064

object_name: prostate cancer


subject: CHEBI:50634

object_name: PMM2-congenital disorder of glycosylation


subject: CHEBI:50634

object_name: congenital disorder of glycosylation type I


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:82975

subject_name: Naloxegol

object_name: kidney failure


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: hepatobiliary disorder


subject: PUBCHEM.COMPOUND:54675783

object_name: liver disorder


subject: PR:000017528

subject_name: tyrosine-protein kinase Yes


subject: PR:000017528


subject: GTOPDB:2509

subject_name: NO


subject: GTOPDB:2509


subject: CHEBI:33396

subject_name: nobelium


subject: CHEBI:33396


subject: CHEBI:16480

subject_name: Nitric Oxide


subject: CHEBI:16480


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Refractory Primary Central Nervous System Neoplasm


subject: GTOPDB:8313

object_name: Recurrent Childhood Central Nervous System Neoplasm


subject: GTOPDB:8313

object_name: Recurrent tumors of the Ewing's family


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: MESH:C434457

subject_name: MCC 135

object_name: heart failure


subject: MESH:C434457

object_name: congestive heart failure


subject: CHEBI:84040

object_name: brain hypoxia


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UMLS:C1456762

object_name: common wart


subject: UMLS:C3274620

subject_name: Bi-functional Alkylating Agent VAL-083

object_name: cancer


subject: UMLS:C3274620

object_name: neoplasm


subject: PUBCHEM.COMPOUND:165505

subject_name: Mercaptopropionylglycine

object_name: cystinuria


subject: CHEBI:32229

subject_name: Tiopronin


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Presenile dementia


subject: CHEBI:73604

object_name: dementia


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:6015


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Alzheimer disease


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Soft tissue rheumatism


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6456

subject_name: Lidocaine


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: metastatic colorectal cancer


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: GTOPDB:13675

subject_name: bentracimab

object_name: Emergency surgery


subject: GTOPDB:13675

object_name: Hemorrhage


subject: CHEMBL.COMPOUND:CHEMBL4594327

subject_name: BENTRACIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594327


subject: UNII:1TBM83QR9S


subject: UNII:1TBM83QR9S


subject: UMLS:C5197925


subject: UMLS:C5197925


subject: UMLS:C0149256

object_name: HIV infection


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Allan-Herndon-Dudley syndrome


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:132922

object_name: cerebral palsy


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:233318

object_name: Metastatic Uveal Melanoma


subject: UMLS:C5555665

subject_name: BRG1/BRM Inhibitor FHD-286


subject: CHEBI:63607

subject_name: Linezolid

object_name: Febrile Neutropenia


subject: CHEBI:63607

object_name: Febrile Neutropenia, CTCAE


subject: MESH:C000615625

subject_name: Qing'e pill

object_name: Menopause present (finding)


subject: MESH:C000615625

object_name: Menopause


subject: PUBCHEM.COMPOUND:1972

subject_name: Fungizone

object_name: leukemia


subject: PUBCHEM.COMPOUND:1972

object_name: childhood leukemia


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:2682


subject: GTOPDB:13768

subject_name: cagrilintide

object_name: chronic kidney disease


subject: GTOPDB:13768

object_name: Chronic Kidney Disease, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4802169

subject_name: CAGRILINTIDE


subject: CHEMBL.COMPOUND:CHEMBL4802169


subject: UMLS:C5706405

subject_name: Bcl-2 Inhibitor ABBV-453

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: panuveitis


subject: PUBCHEM.COMPOUND:633097

object_name: choroiditis


subject: PUBCHEM.COMPOUND:633097

object_name: posterior uveitis


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Postmenopausal


subject: CHEBI:231614

subject_name: Nivolumab

object_name: adult acute myeloid leukemia


subject: UMLS:C2346820


subject: CHEBI:4757

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:4757

object_name: acute myeloid leukemia


subject: CHEBI:4757

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:4757

object_name: childhood myelodysplastic syndrome


subject: CHEBI:4757

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:4757

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:4757

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:4757

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:4757

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:4757

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:4757

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:4757

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:4757

object_name: Refractory acute myeloid leukemia


subject: CHEBI:4757

object_name: Very High Risk Myelodysplastic Syndrome


subject: CHEBI:4757

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:4757


subject: CHEBI:4757

object_name: Blast Phase


subject: CHEBI:4757

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:4757

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4757

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4757

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:4735

subject_name: Edetic acid

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:4735

object_name: acute myeloid leukemia


subject: CHEBI:4735

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:4735

object_name: childhood myelodysplastic syndrome


subject: CHEBI:4735

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:4735

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:4735

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:4735

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:4735

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:4735

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:4735

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:4735

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:4735

object_name: Refractory acute myeloid leukemia


subject: CHEBI:4735

object_name: Very High Risk Myelodysplastic Syndrome


subject: CHEBI:4735

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:4735


subject: CHEBI:4735

object_name: Blast Phase


subject: CHEBI:4735

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:4735

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4735

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4735

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0301532

object_name: acute myeloid leukemia


subject: UMLS:C0301532

object_name: Myelodysplasia


subject: UMLS:C0301532

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0301532

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0301532

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0301532

object_name: Secondary Myelodysplastic Syndrome


subject: UMLS:C0301532

object_name: High Risk Myelodysplastic Syndrome


subject: UMLS:C0301532

object_name: Recurrent Myelodysplastic Syndrome


subject: UMLS:C0301532

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UMLS:C0301532

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C0301532

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C0301532

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C0301532

object_name: Refractory acute myeloid leukemia


subject: UMLS:C0301532

object_name: Very High Risk Myelodysplastic Syndrome


subject: UMLS:C0301532

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UMLS:C0301532


subject: UMLS:C0301532

object_name: Blast Phase


subject: UMLS:C0301532

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0301532

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C0301532

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C0301532

object_name: myeloproliferative neoplasm


subject: UMLS:C0301532

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:63623

subject_name: Succimer

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:63623

object_name: acute myeloid leukemia


subject: CHEBI:63623

object_name: Myelodysplasia


subject: CHEBI:63623

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:63623

object_name: childhood myelodysplastic syndrome


subject: CHEBI:63623

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:63623

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:63623

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:63623

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:63623

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:63623

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:63623

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:63623

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:63623

object_name: Refractory acute myeloid leukemia


subject: CHEBI:63623

object_name: Very High Risk Myelodysplastic Syndrome


subject: CHEBI:63623

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:63623


subject: CHEBI:63623

object_name: Blast Phase


subject: CHEBI:63623

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:63623

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:63623

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:63623

object_name: myeloproliferative neoplasm


subject: CHEBI:63623

object_name: Malignant myeloproliferative neoplasm


subject: GTOPDB:9596

subject_name: oleclumab

object_name: Solid Neoplasm


subject: UNII:5CRY01URYQ

subject_name: OLECLUMAB


subject: UMLS:C4085967

subject_name: Oleclumab


subject: CHEBI:76842

object_name: spinal disease


subject: CHEBI:28001

subject_name: Vancomycin


subject: GTOPDB:11594

subject_name: nogapendekin alfa

object_name: Stage III Lung Cancer AJCC v8


subject: GTOPDB:11594

object_name: Non-small cell lung cancer recurrent


subject: GTOPDB:11594

object_name: Stage IV Lung Cancer AJCC v8


subject: GTOPDB:11594

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: GTOPDB:11594

object_name: Stage IIIA Lung Cancer AJCC v8


subject: GTOPDB:11594

object_name: Stage IVA Lung Cancer AJCC v8


subject: GTOPDB:11594

object_name: Stage IIIB Lung Cancer AJCC v8


subject: GTOPDB:11594

object_name: Stage IIIC Lung Cancer AJCC v8


subject: GTOPDB:11594

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297690

subject_name: NOGAPENDEKIN ALFA


subject: CHEMBL.COMPOUND:CHEMBL4297690


subject: CHEMBL.COMPOUND:CHEMBL4297690


subject: CHEMBL.COMPOUND:CHEMBL4297690


subject: CHEMBL.COMPOUND:CHEMBL4297690


subject: CHEMBL.COMPOUND:CHEMBL4297690


subject: CHEMBL.COMPOUND:CHEMBL4297690


subject: CHEMBL.COMPOUND:CHEMBL4297690


subject: CHEMBL.COMPOUND:CHEMBL4297690


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3659483

object_name: ovarian carcinoma


subject: UMLS:C3659483

object_name: malignant epithelial tumor of ovary


subject: UMLS:C3659483

object_name: fallopian tube carcinoma


subject: UMLS:C3659483

object_name: fallopian tube cancer


subject: UMLS:C3659483

object_name: primary peritoneal carcinoma


subject: UMLS:C3659483

object_name: Primary Peritoneal Cancer


subject: CHEBI:5779

subject_name: Hydrocodone

object_name: Drug Interactions


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: neurotoxicity


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:71417

subject_name: Procarbazine


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: ventilator-associated pneumonia


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Metastatic Bladder Urothelial Carcinoma


subject: CHEBI:95021

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:63724


subject: CHEBI:63724


subject: DRUGBANK:DB17394

subject_name: fb-PMT

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:135483998

object_name: habitual spontaneous abortion


subject: PUBCHEM.COMPOUND:135402010


subject: CHEBI:20612


subject: CHEBI:15641

subject_name: 5-methyltetrahydrofolic acid


subject: CHEBI:9635

subject_name: Toremifene

object_name: prostate carcinoma


subject: CHEBI:9635

object_name: prostate cancer


subject: UMLS:C4329329

object_name: superficial urinary bladder carcinoma


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Severe Sepsis


subject: UNII:5TAA004E22

object_name: septic shock


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C5447779

subject_name: Axl/Mer/CSF1R Inhibitor Q702

object_name: Childhood Solid Neoplasm


subject: UMLS:C5447779

object_name: Adult Solid Neoplasm


subject: UMLS:C5447779

object_name: Solid Neoplasm


subject: UMLS:C5447779

object_name: Advanced cancer


subject: UMLS:C5447779

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5447779

object_name: Embolism, Tumor


subject: UMLS:C5447779

object_name: Neoplasm Metastasis


subject: UMLS:C5555503

subject_name: Anti-CSF1R Monoclonal Antibody AMB-05X

object_name: testicular germ cell tumor


subject: UMLS:C0032145

subject_name: Plasminogen Inactivators

object_name: Post-Operative Pain


subject: PR:000014702

subject_name: plasminogen activator inhibitor 1


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: kidney failure


subject: CHEBI:192614

object_name: Renal dysfunction


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: PUBCHEM.COMPOUND:9867822

subject_name: Lestaurtinib

object_name: leukemia


subject: PUBCHEM.COMPOUND:9867822

object_name: childhood leukemia


subject: CHEBI:91471


subject: CHEBI:91471


subject: CHEBI:78570

subject_name: beta-aminoarteether maleate

object_name: EXCESS LMW-DNA


subject: UMLS:C2934718


subject: UMLS:C5815531

subject_name: VaxSyn

object_name: Pregnant


subject: UMLS:C5815618

subject_name: Gp160 Vaccine


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Frontal balding


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEMBL.COMPOUND:CHEMBL2109613

object_name: Crohn disease


subject: UMLS:C4507552


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: pemphigus vulgaris


subject: CHEBI:4672

subject_name: Docetaxel

object_name: malignant tumor of nasopharynx


subject: UMLS:C3485429

subject_name: Probiotic Formula

object_name: Prolonged neonatal jaundice


subject: UNII:NY0COC51FI

subject_name: Tradipitant

object_name: atopic eczema


subject: CHEBI:74705

subject_name: Met-Leu

object_name: cervical intraepithelial neoplasia


subject: CHEBI:74705

object_name: Chronic idiopathic neutropenia


subject: CHEBI:74705

object_name: cervical squamous intraepithelial neoplasia


subject: CHEBI:74705

object_name: dysplasia of cervix


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:23044

subject_name: carotenoid

object_name: skin disorder


subject: CHEBI:35147

subject_name: alpha-Carotene


subject: CHEBI:74705

object_name: Cough


subject: CHEBI:74705

object_name: Cough, CTCAE


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:177547

subject_name: Velneperit

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:177547

object_name: obesity


subject: CHEBI:177547

object_name: Obesity, CTCAE


subject: UNII:09BQ2KJ22J


subject: UNII:09BQ2KJ22J


subject: UNII:09BQ2KJ22J


subject: UMLS:C4519749


subject: UMLS:C4519749


subject: UMLS:C4519749


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: Secondary pulmonary hypertension


subject: CHEBI:75998

subject_name: Trametinib

object_name: tumor suppressor gene on chromosome 11


subject: PUBCHEM.COMPOUND:60152613

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:60152613

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:60152613

object_name: thyroid cancer


subject: PUBCHEM.COMPOUND:60152613

object_name: cancer


subject: PUBCHEM.COMPOUND:60152613

object_name: neoplasm


subject: PUBCHEM.COMPOUND:60152613

object_name: melanoma


subject: PUBCHEM.COMPOUND:60152613

object_name: BRAF V600 Protein Variation


subject: PUBCHEM.COMPOUND:60152613

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:60152613

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:60152613

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:60152613


subject: PUBCHEM.COMPOUND:60152613

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:60152613

object_name: lung cancer


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: DRUGBANK:DB18780


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Primary malignant neoplasm


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF

object_name: childhood malignant neoplasm


subject: UNII:6XC1PAD3KF

object_name: Malignant obstetric neoplasm


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: UMLS:C4744685

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C3272413

subject_name: STAT3 Inhibitor OPB-51602

object_name: nasopharyngeal carcinoma


subject: UMLS:C3272413

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: prostate cancer


subject: UNII:15C2VL427D

object_name: prostate neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743018

subject_name: FICLATUZUMAB

object_name: Refractory acute myeloid leukemia


subject: UMLS:C2703138

subject_name: ficlatuzumab


subject: DRUGBANK:DB17743

subject_name: Fecal microbiota

object_name: HIV infection


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:4568

subject_name: Nystatin A1

object_name: dental caries


subject: PUBCHEM.COMPOUND:4568

object_name: Dental Caries, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5465559

subject_name: NYSTATIN


subject: CHEMBL.COMPOUND:CHEMBL5465559


subject: CHEBI:7660

subject_name: nystatin


subject: CHEBI:7660


subject: CHEBI:23965

subject_name: estradiol

object_name: Drug Interactions


subject: CHEBI:23965

object_name: Adverse drug interaction


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Renal cancer recurrent


subject: UMLS:C1541394

subject_name: TRAIL-R1 mAb

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C1541394

object_name: non-Hodgkin lymphoma


subject: CHEBI:94688

subject_name: Acipimox

object_name: maturity-onset diabetes of the young type 1


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT

object_name: Depressed mood


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: Cancer patients and suicide and depression


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: Depressed - symptom


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: Depression, CTCAE


subject: CHEBI:4877

subject_name: Ethambutol

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:4877

object_name: obesity


subject: CHEBI:4877

object_name: Obesity, CTCAE


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Immunosuppression


subject: UNII:B72HH48FLU

object_name: Decreased Immunologic Activity [PE]


subject: MESH:D007166

subject_name: Immunosuppressive Agents


subject: MESH:D007166


subject: MESH:D007166

object_name: inflammatory bowel disease 1


subject: CHEBI:46295

subject_name: Vardenafil

object_name: AIDS


subject: UNII:NGB50MQK8N

object_name: acute coronary syndrome


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0770694

object_name: clear cell renal carcinoma


subject: UMLS:C0770694

object_name: renal cell adenocarcinoma


subject: UMLS:C0770694

object_name: renal cell carcinoma


subject: UMLS:C0770694

object_name: Plexosarcoma


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: MESH:D007252


subject: MESH:D007252


subject: MESH:D007252


subject: MESH:D007252


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C2700362

subject_name: Lymphoseek

object_name: Cancer of Neck


subject: UMLS:C2700362

object_name: Cancer of Head


subject: UMLS:C0247623

subject_name: nanocoll

object_name: melanoma


subject: UMLS:C0247623

object_name: Childhood Breast Carcinoma


subject: UMLS:C0247623

object_name: breast carcinoma


subject: UMLS:C0247623

object_name: breast cancer


subject: UMLS:C0247623


subject: UMLS:C0247623


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: End stage cardiac failure


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:6QU69VIG75

subject_name: Tetulomab tetraxetan Lu-177

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:6QU69VIG75

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C4722513

subject_name: Betalutin


subject: UMLS:C4722513


subject: UMLS:C4519092

subject_name: tetulomab tetraxetan lu-177


subject: UMLS:C4519092


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Chronic low back pain


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: myeloproliferative neoplasm


subject: UMLS:C0013227

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C0013227

object_name: Splanchnic vein thrombosis


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Increased reactive oxygen species production


subject: UMLS:C1250042

object_name: Inflammation


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine

object_name: Infantile Colic


subject: PUBCHEM.COMPOUND:160883

object_name: Abdominal colic


subject: PUBCHEM.COMPOUND:21937662

subject_name: Isavuconazole

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:21937662

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:21937662

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:21937662


subject: PUBCHEM.COMPOUND:21937662

object_name: bone marrow neoplasm


subject: UNII:EF7PK2TQ0U

object_name: cutaneous lupus erythematosus


subject: UMLS:C4329319

subject_name: Anti-CSF1 Monoclonal Antibody PD-0360324


subject: UMLS:C4733602

object_name: Childhood Solid Neoplasm


subject: UMLS:C4733602

object_name: Adult Solid Neoplasm


subject: UMLS:C4733602

object_name: Solid Neoplasm


subject: UMLS:C4733602

object_name: refractory malignant neoplasm


subject: UMLS:C4733602

object_name: cancer


subject: UMLS:C4733602

object_name: neoplasm


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: UMLS:C1174783

subject_name: Zarnestra


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: outcomes general quality of life


subject: CHEBI:38290

object_name: Perceived quality of life


subject: CHEBI:38290

object_name: Good quality of life


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage I Prostate Cancer AJCC v6


subject: UNII:2S9ZZM9Q9V

object_name: Prostate cancer stage I


subject: UNII:2S9ZZM9Q9V

object_name: Stage I Prostate Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage I Prostate Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Prostate Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Prostate Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Carcinoma of the prostate stage III


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Prostate Cancer AJCC v6


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Prostate Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Prostate Cancer AJCC v8


subject: UNII:1C854K1MIJ

subject_name: Apitolisib

object_name: prostate carcinoma


subject: UNII:1C854K1MIJ

object_name: prostate cancer


subject: UMLS:C5854503

subject_name: EED Inhibitor BR1733

object_name: Advanced cancer


subject: UMLS:C5854503

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C5854503

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5854503

object_name: follicular lymphoma


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: Supraventricular tachycardia


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Lumbar radiculopathy


subject: CHEBI:7986

object_name: lumbar disk disease


subject: CHEBI:7986

object_name: lumbar disk degenerative disorder


subject: CHEBI:7986

object_name: lumbar disc herniation


subject: UMLS:C4018592

subject_name: LEVOMEFOLATE MAGNESIUM 5.23 mg / LEUCOVORIN 2.5 mg / FOLIC ACID 1 mg / FERROUS CYSTEINE GLYCINATE 13.6 mg / MAGNESIUM ASCORBATE 24 mg / ZINC ASCORBATE 1 mg / COCARBOXYLASE 25 ug / FLAVIN ADENINE DINUCLEOTIDE 25 ug / NADH 25 ug / PYRIDOXAL PHOSPHATE ANHYDROUS 25 ug / COBAMAMIDE 50 ug / BETAINE 500 ug / MAGNESIUM L-THREONATE 1 mg / 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 6.4 mg / 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 800 ug / PHOSPHATIDYL SERINE 12 mg ORAL CAPSULE, DELAYED RELEASE PELLETS [EnBrace HR]

object_name: premenstrual tension


subject: UMLS:C4018592

object_name: polydactyly-myopia syndrome


subject: UMLS:C4018592

object_name: Premenstrual Dysphoric Disorder


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate

object_name: metabolic bone disorder


subject: UMLS:C0721124

subject_name: Iron Supplement

object_name: cerebral palsy


subject: UMLS:C2825025

subject_name: Iron Supplement [EPC]


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: UNII:856DX0KJ84

subject_name: Neramexane

object_name: Alzheimer disease


subject: UMLS:C1142931

subject_name: neramexane


subject: UMLS:C1699394

subject_name: Hylenex

object_name: smoldering plasma cell myeloma


subject: UMLS:C5439904


subject: CHEBI:15365

subject_name: Aspirin

object_name: Encounter due to In vitro fertilization


subject: CHEBI:3286

subject_name: Cabergoline


subject: PUBCHEM.COMPOUND:126480232

subject_name: Cobomarsen

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:126480232

object_name: primary cutaneous T-cell lymphoma


subject: UNII:3JKW7CI9IU

subject_name: COBOMARSEN


subject: UNII:3JKW7CI9IU


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: cancer pain


subject: UMLS:C1328728

object_name: Colostomy stoma


subject: CHEBI:31932

subject_name: olmesartan

object_name: proteinuria


subject: CHEBI:31932

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:31932

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:31932

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:35526

subject_name: hypoglycemic agent

object_name: cardiovascular disorder


subject: CHEBI:35526

object_name: hypertension


subject: CHEBI:35526

object_name: Hypertension, CTCAE


subject: CHEBI:35526

object_name: Hypercholesterolemia


subject: CHEBI:35526

object_name: coronary artery disorder


subject: CHEBI:35526

object_name: arteriosclerosis disorder


subject: CHEBI:35526

object_name: atherosclerosis


subject: UMLS:C0020616

subject_name: Hypoglycemic Agents


subject: UMLS:C0020616


subject: UMLS:C0020616


subject: UMLS:C0020616


subject: UMLS:C0020616


subject: UMLS:C0020616


subject: UMLS:C0020616


subject: UMLS:C0684167

subject_name: hypertensive agents


subject: UMLS:C0684167

object_name: diabetes mellitus


subject: UMLS:C0684167


subject: UMLS:C0684167


subject: UMLS:C0684167


subject: UMLS:C0684167


subject: UMLS:C0684167


subject: UMLS:C0684167


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: oral candidiasis


subject: CHEBI:45081

subject_name: Pentamidine

object_name: colorectal cancer


subject: CHEBI:45081

object_name: colorectal carcinoma


subject: CHEBI:45081

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:6801

subject_name: Metformin

object_name: Cognitive impairment


subject: CHEBI:6801

object_name: childhood medulloblastoma


subject: GTOPDB:2479

subject_name: HCl


subject: GTOPDB:2479


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C1512523


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: UMLS:C0443985


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:17883


subject: UNII:U9DE68P1CA

object_name: bronchiectasis


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: peripheral vascular disease


subject: UNII:PP0SHH6V16

object_name: peripheral arterial disease


subject: MESH:C000603981

object_name: arteriovenous hemangioma/malformation


subject: MESH:C000603981

object_name: lymphedema


subject: MESH:C000603981

object_name: Lymphedema, CTCAE


subject: MESH:C000603981

object_name: hemangioma


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: brain cancer


subject: CHEBI:72317

object_name: Brain Stem Glioblastoma


subject: CHEBI:72317

object_name: glioma susceptibility 1


subject: CHEBI:72317

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:72317

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:72317

object_name: anaplastic astrocytoma


subject: CHEBI:72317

object_name: High grade glioma


subject: CHEBI:72317

object_name: malignant glioma


subject: UMLS:C5420065

subject_name: Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5420065

object_name: squamous cell lung carcinoma


subject: UMLS:C5420065

object_name: non-small cell squamous lung carcinoma


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:T4H8FMA7IM

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: GTOPDB:10140

subject_name: spartalizumab


subject: UNII:QOG25L6Z8Z


subject: UMLS:C4053607


subject: CHEBI:40279

subject_name: Allopurinol

object_name: dilated cardiomyopathy


subject: CHEBI:40279

object_name: heart disorder


subject: CHEBI:31355

subject_name: Carboplatin

object_name: malignant neoplasm of breast stage I


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:6A901E312A

object_name: Stage IA Breast Cancer AJCC v7


subject: UNII:6A901E312A

object_name: Stage IB Breast Cancer AJCC v7


subject: UNII:6A901E312A

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:6A901E312A

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:6A901E312A

object_name: Stage IIIA Breast Carcinoma


subject: UNII:6A901E312A

object_name: Stage IIIB Breast Carcinoma


subject: UNII:6A901E312A

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:6A901E312A

object_name: Stage IIB Breast Carcinoma


subject: UNII:6A901E312A

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:23965

subject_name: estradiol

object_name: brain aneurysm


subject: CHEBI:52854

subject_name: gold nanocrystal

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:52854

object_name: amyotrophic lateral sclerosis


subject: CHEBI:182618

subject_name: Methylone

object_name: Alcohol or Other Drugs use


subject: CHEBI:182618

object_name: substance use (history)


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Phosphate overload


subject: CHEBI:26710

object_name: Obesity, Visceral


subject: CHEBI:26710

object_name: Lack of sufficient daily physical activity


subject: CHEBI:34683


subject: CHEBI:34683


subject: CHEBI:34683


subject: CHEBI:37583

subject_name: trisodium phosphate


subject: CHEBI:37583


subject: CHEBI:37583


subject: GTOPDB:13402

subject_name: garadacimab

object_name: hereditary angioedema


subject: UNII:32W6AJL0DY

subject_name: GARADACIMAB


subject: CHEBI:67271

object_name: adult hepatocellular carcinoma


subject: UMLS:C4331414

subject_name: timolumab

object_name: sclerosing cholangitis


subject: UMLS:C4331414

object_name: primary sclerosing cholangitis


subject: CHEBI:231415

subject_name: DENSPM

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:74412639

subject_name: Solithromycin

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:74412639

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4079949

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C4079949

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:865UEK4EJC

subject_name: Elobixibat


subject: UNII:865UEK4EJC

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:59594

subject_name: Colesevelam

object_name: Chronic liver disease


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: amphetamine abuse


subject: UMLS:C3275324

object_name: Lennox-Gastaut syndrome


subject: UNII:08AN7WA2G0

subject_name: TRIPTORELIN PAMOATE

object_name: EXCESS LMW-DNA


subject: UMLS:C1145204

subject_name: INJECTION, TRIPTORELIN PAMOATE, 3.75 MG ADMINISTERED


subject: CHEBI:63633

subject_name: Triptorelin


subject: UMLS:C0112708

subject_name: Trelstar


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Metastatic Uveal Melanoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: Unexplained infertility


subject: UNII:VV3HN9ZPB5

subject_name: FOLLITROPIN ALFA


subject: UMLS:C4759807

subject_name: TSH, alpha Subunit


subject: UMLS:C1268876

subject_name: follitropin alfa


subject: CHEBI:10023

subject_name: Voriconazole

object_name: fungal keratitis


subject: CHEBI:46295

subject_name: Vardenafil

object_name: Cirrhosis


subject: CHEBI:46295

object_name: liver cirrhosis


subject: UMLS:C2703133

object_name: lymphoma


subject: UMLS:C2703133

object_name: B-cell neoplasm


subject: CHEBI:231350

subject_name: Pacritinib


subject: CHEBI:231350


subject: CHEBI:67079

subject_name: anti-inflammatory agent

object_name: Shoulder dislocation


subject: UMLS:C0003209

subject_name: Anti-Inflammatory Agents


subject: UMLS:C3854073

subject_name: Capsaicin 8% patch, per square centimeter

object_name: fibromyalgia


subject: CHEBI:2677

subject_name: Augmentin

object_name: Traumatic Wound


subject: CHEBI:2677

object_name: Injury


subject: CHEBI:2677

object_name: Wounds and Injuries


subject: CHEBI:2677

object_name: bite injury


subject: CHEBI:2677

object_name: Dental Occlusion


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: CHEBI:142708

object_name: staphylococcal infection


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: CHEBI:149836

subject_name: Tigecycline


subject: UNII:O3571H3R8N

subject_name: Enobosarm

object_name: Carcinoma breast stage IV


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide

object_name: Hot Flashes, CTCAE


subject: UNII:3A3U0GI71G

object_name: Hot flashes


subject: UNII:3A3U0GI71G

object_name: Childhood Breast Carcinoma


subject: UNII:3A3U0GI71G

object_name: breast carcinoma


subject: UNII:3A3U0GI71G

object_name: breast cancer


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:31794


subject: UMLS:C5908059

subject_name: Anti-CLDN18.2/CD47 Bispecific Antibody AK132

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:17632

subject_name: Nitrate

object_name: osteoporosis


subject: CHEBI:17632

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:17632

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:17632

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: necrotizing fasciitis


subject: CHEBI:78538

object_name: polyneuropathy


subject: CHEBI:95073

subject_name: Ricolinostat

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C3272774


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: metastatic colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL3545343

object_name: asthma


subject: CHEBI:44915

subject_name: Propofol

object_name: metastatic malignant neoplasm in the brain


subject: UNII:GKK5LY2UEI

object_name: Alzheimer disease


subject: CHEBI:15377

subject_name: Water

object_name: fragile X syndrome


subject: UNII:77520S18SE

subject_name: MIDAZOLAM MALEATE

object_name: psoriasis


subject: UMLS:C3273933

subject_name: Hafnium oxide-containing nanoparticles nbtxr3

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C3273933

object_name: age


subject: UMLS:C0032200

subject_name: Platelet-Derived Growth Factor

object_name: Peri-Implantitis


subject: CHEBI:67194

subject_name: Nabiximols

object_name: Tourette syndrome


subject: CHEBI:67194

object_name: tic disorder


subject: MESH:C568072

subject_name: arepanrix

object_name: swine influenza


subject: MESH:C568072

object_name: HIV infection


subject: CHEBI:23965

subject_name: estradiol

object_name: postmenopausal osteoporosis


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:63633

subject_name: Triptorelin


subject: CHEBI:231679

subject_name: ipilimumab

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:231679

object_name: Cholangiocarcinoma recurrent


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367

object_name: malignant peritoneal mesothelioma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: arthropathy


subject: CHEBI:3770

object_name: Joint Infection, CTCAE


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: RXCUI:151399

subject_name: Bactrim


subject: RXCUI:151399


subject: CHEBI:53667

subject_name: Cefadroxil


subject: CHEBI:53667


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:3745


subject: CHEBI:652992

subject_name: doxycycline HCl


subject: CHEBI:652992


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: Pemphigoid


subject: CHEBI:59905

object_name: hyperglycemia


subject: CHEBI:59905

object_name: Hyperglycemia, CTCAE


subject: CHEBI:59905

object_name: Glucose in blood specimen above reference range


subject: CHEBI:59905

object_name: Sepsis


subject: CHEBI:59905

object_name: Sepsis, CTCAE


subject: CHEBI:18243

subject_name: Dopamine


subject: CHEBI:18243


subject: CHEBI:18243


subject: CHEBI:18243


subject: CHEBI:18243


subject: CHEBI:231614

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:231614

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:5B38CV1212

object_name: Overweight


subject: UMLS:C3886550


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Infection


subject: CHEBI:33569

object_name: Infection of musculoskeletal system


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:4670

subject_name: Dobutamine


subject: CHEBI:4670


subject: CHEBI:4670

object_name: Severe Sepsis


subject: CHEBI:64073

object_name: cardiac arrest


subject: CHEBI:64073

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:64073

object_name: ocular motor apraxia, Cogan type


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: CHEBI:17754

subject_name: Glycerin

object_name: Feeding Intolerance


subject: CHEBI:17754

object_name: Feeding Intolerance, AE


subject: UMLS:C3896789

object_name: glioblastoma


subject: UMLS:C3896789

object_name: Childhood Glioblastoma


subject: UMLS:C3896789

object_name: adult glioblastoma


subject: CHEBI:63623

subject_name: Succimer

object_name: adult acute myeloid leukemia


subject: CHEBI:63623

object_name: childhood acute myeloid leukemia


subject: PR:000022455

subject_name: anaerobic dimethyl sulfoxide reductase chain A


subject: PR:000022455


subject: PR:000022455

object_name: acute myeloid leukemia


subject: UniProtKB:P18775

subject_name: DMSA_ECOLI Dimethyl sulfoxide reductase DmsA (sprot)


subject: UniProtKB:P18775


subject: UniProtKB:P18775


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:32599


subject: UMLS:C0301532

subject_name: Multivitamin preparation


subject: UMLS:C0301532


subject: UMLS:C5666996

subject_name: CDK4/6 Inhibitor UCT-03-008

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4682501

subject_name: Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502

object_name: non-small cell lung carcinoma


subject: UMLS:C4682501

object_name: gastroesophageal cancer


subject: UMLS:C4682501

object_name: bladder tumor


subject: UMLS:C4682501

object_name: urinary bladder carcinoma


subject: UMLS:C4682501

object_name: urinary bladder cancer


subject: UMLS:C4682501

object_name: childhood bladder carcinoma


subject: UMLS:C4682501

object_name: Childhood Breast Carcinoma


subject: UMLS:C4682501

object_name: breast carcinoma


subject: UMLS:C4682501

object_name: breast cancer


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:14907381

object_name: ependymoma


subject: PUBCHEM.COMPOUND:14907381

object_name: childhood ependymoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Newly Diagnosed Childhood Ependymoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Adult Ependymoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: autoimmune encephalitis


subject: CHEBI:8774

subject_name: Ramipril

object_name: rheumatoid arthritis


subject: UMLS:C0939246

subject_name: Advair Diskus

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C0939246

object_name: COPD, severe early onset


subject: CHEBI:229764

subject_name: Selinexor

object_name: Recurrent Glioblastoma, IDH-Wildtype


subject: CHEBI:229764

object_name: MGMT-Methylated Glioblastoma


subject: CHEBI:229764

object_name: Recurrent MGMT-Methylated Glioblastoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:6801

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:6801

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:6801

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:6801

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:6801

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:6801

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:6801

object_name: stage IIIC primary peritoneal cavity cancer


subject: CHEBI:6801

object_name: stage IIIA primary peritoneal cavity cancer


subject: CHEBI:6801

object_name: stage IIIB primary peritoneal cavity cancer


subject: CHEBI:6801

object_name: stage IV primary peritoneal cavity cancer


subject: CHEBI:6801

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: Ovarian cancer stage IV


subject: CHEBI:6801

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:6801

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:6801

object_name: FIGO Stage IIIC Ovarian Cancer


subject: CHEBI:6801

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:6801

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: FIGO Stage IIIA Ovarian Cancer


subject: CHEBI:6801

object_name: stage IIIB ovarian epithelial cancer


subject: CHEBI:6801

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: stage IIIC ovarian germ cell tumor


subject: CHEBI:6801

object_name: Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:6801

object_name: stage IIIB ovarian germ cell tumor


subject: CHEBI:6801

object_name: Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:6801

object_name: stage IIIA ovarian germ cell tumor


subject: CHEBI:6801

object_name: Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:6801

object_name: ovarian undifferentiated adenocarcinoma


subject: CHEBI:6801

object_name: ovarian seromucinous carcinoma


subject: CHEBI:6801

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:6801

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:6801

object_name: ovarian Brenner tumor


subject: CHEBI:6801

object_name: Brenner tumor


subject: CHEBI:6801

object_name: Malignant pleural effusion


subject: CHEBI:6801

object_name: Malignant ascites


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: malignant neoplasm of breast stage I


subject: UNII:P0GVQ9A4S5

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Carcinoma breast stage I


subject: UNII:P0GVQ9A4S5

object_name: Breast cancer stage II


subject: UNII:P0GVQ9A4S5

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:P0GVQ9A4S5

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:P0GVQ9A4S5

object_name: Breast cancer stage III


subject: UNII:P0GVQ9A4S5

object_name: Stage III Breast Cancer AJCC v6


subject: UNII:P0GVQ9A4S5

object_name: Germline BRCA1 Gene Mutation


subject: UNII:P0GVQ9A4S5

object_name: Germline BRCA2 Gene Mutation


subject: UNII:P0GVQ9A4S5

object_name: Deleterious PALB2 Gene Mutation


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: gene mutation-related cancer


subject: GTOPDB:9592

object_name: Tumor Escape


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Uterine Inertia


subject: UMLS:C3641169

object_name: adult lymphoma


subject: UMLS:C3641169

object_name: lymphoma


subject: UMLS:C3641169

object_name: pediatric lymphoma


subject: UMLS:C3641169

object_name: esophageal adenocarcinoma


subject: UMLS:C3641169

object_name: lung adenocarcinoma


subject: UMLS:C3641169

object_name: cervical adenocarcinoma


subject: UMLS:C3641169

object_name: adenocarcinoma


subject: UMLS:C3641169

object_name: bile duct adenocarcinoma


subject: UMLS:C3641169

object_name: gastric adenocarcinoma


subject: UMLS:C3641169

object_name: neoplasm


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: Refractory Grade 3a Follicular Lymphoma


subject: UNII:D6OMY2L0WA

object_name: Refractory Grade 2 Follicular Lymphoma


subject: UNII:D6OMY2L0WA

object_name: Refractory Grade 1 Follicular Lymphoma


subject: UNII:D6OMY2L0WA

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UNII:D6OMY2L0WA

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:D6OMY2L0WA

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: CHEBI:231598

subject_name: Tazemetostat


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: UMLS:C5556655

subject_name: Anti-CD137 Agonistic Monoclonal Antibody EU101

object_name: non-small cell lung carcinoma


subject: UMLS:C5556655

object_name: Childhood Solid Neoplasm


subject: UMLS:C5556655

object_name: Adult Solid Neoplasm


subject: UMLS:C5556655

object_name: Solid Neoplasm


subject: UMLS:C5556655

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C5556655

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C5556655

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5556655

object_name: clear cell renal carcinoma


subject: UMLS:C5556655

object_name: renal cell adenocarcinoma


subject: UMLS:C5556655

object_name: renal cell carcinoma


subject: UMLS:C5556655

object_name: prostate carcinoma


subject: UMLS:C5556655

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:139033020

subject_name: Bovine intestinal alkaline phosphatase

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:139033020

object_name: inflammatory bowel disease 1


subject: UNII:CMY8668SAQ

subject_name: BOVINE INTESTINAL ALKALINE PHOSPHATASE


subject: UNII:CMY8668SAQ


subject: PUBCHEM.COMPOUND:126664


subject: PUBCHEM.COMPOUND:126664


subject: UNII:1WX8O5XV4R

subject_name: Erbumine

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: UNII:1WX8O5XV4R

object_name: Advanced Lung Non-Squamous Non-Small Cell Carcinoma


subject: UNII:1WX8O5XV4R

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:1WX8O5XV4R

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:1WX8O5XV4R

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:1WX8O5XV4R

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:1WX8O5XV4R

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:1WX8O5XV4R

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:1WX8O5XV4R

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UMLS:C5235404

subject_name: Aurora a kinase inhibitor ly3295668


subject: UMLS:C5235404


subject: UMLS:C5235404


subject: UMLS:C5235404


subject: UMLS:C5235404


subject: UMLS:C5235404


subject: UMLS:C5235404


subject: UMLS:C5235404


subject: UMLS:C5235404


subject: UMLS:C5761796

subject_name: GVAX

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820

object_name: HER2/Neu Negative


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:33330

subject_name: scandium atom

object_name: psoriatic arthritis


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:145372

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: CHEBI:145372


subject: UMLS:C1452745

object_name: kidney failure


subject: UMLS:C1452745

object_name: kidney disorder


subject: UMLS:C1452745

object_name: impaired renal function disease


subject: PUBCHEM.COMPOUND:121364971

object_name: rheumatoid arthritis


subject: MESH:C568861

object_name: open-angle glaucoma


subject: MESH:C568861

object_name: ocular hypertension


subject: MESH:C568861

object_name: Ocular hypertension


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Metastatic Colorectal Adenocarcinoma


subject: CHEBI:3001

subject_name: beclomethasone

object_name: Cough


subject: CHEBI:3001

object_name: Cough, CTCAE


subject: UMLS:C5418101

object_name: Childhood Solid Neoplasm


subject: UMLS:C5418101

object_name: Adult Solid Neoplasm


subject: UMLS:C5418101

object_name: Solid Neoplasm


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN

object_name: coronary artery disorder


subject: UNII:IY90U61Z3S

object_name: coronary atherosclerosis


subject: UNII:IY90U61Z3S

object_name: angina unstable


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: UNII:0DW7MIH1VX


subject: UNII:0DW7MIH1VX


subject: CHEBI:48720

subject_name: argatroban


subject: CHEBI:48720


subject: CHEBI:48720


subject: UMLS:C3896800

subject_name: DNA (recombinant human telomerase-specific replication-competent oncolytic adenovirus 5 vector OBP-301)

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:85540151

object_name: Brain fog


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: UMLS:C5706286

subject_name: Jing Si Herbal Tea

object_name: outcomes general quality of life


subject: UMLS:C5706286

object_name: Perceived quality of life


subject: UMLS:C5706286

object_name: Good quality of life


subject: UMLS:C5706286

object_name: Presenile dementia


subject: UMLS:C5706286

object_name: dementia


subject: CHEBI:135905

subject_name: Terlipressin

object_name: Bleeding varices


subject: CHEBI:6541

subject_name: Losartan

object_name: Vascular Access Complication


subject: CHEBI:6541

object_name: Vascular Access Complication, CTCAE


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Fractured humerus


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:4670

subject_name: Dobutamine

object_name: Hemodynamic instability